2016 Q2 Form 10-Q Financial Statement
#000156459016022692 Filed on August 04, 2016
Income Statement
Concept | 2016 Q2 | 2015 Q2 |
---|---|---|
Revenue | $891.0K | $306.0K |
YoY Change | 191.18% | 209.09% |
Cost Of Revenue | $168.0K | $0.00 |
YoY Change | ||
Gross Profit | $723.0K | $306.0K |
YoY Change | 136.27% | |
Gross Profit Margin | 81.14% | 100.0% |
Selling, General & Admin | $5.056M | $4.622M |
YoY Change | 9.39% | 25.09% |
% of Gross Profit | 699.31% | 1510.46% |
Research & Development | $4.444M | $4.142M |
YoY Change | 7.29% | 47.19% |
% of Gross Profit | 614.66% | 1353.59% |
Depreciation & Amortization | $251.0K | $135.0K |
YoY Change | 85.93% | 40.63% |
% of Gross Profit | 34.72% | 44.12% |
Operating Expenses | $9.500M | $8.764M |
YoY Change | 8.4% | 34.64% |
Operating Profit | -$8.777M | -$8.458M |
YoY Change | 3.77% | 31.95% |
Interest Expense | $30.00K | $3.000K |
YoY Change | 900.0% | |
% of Operating Profit | ||
Other Income/Expense, Net | $32.00K | -$33.00K |
YoY Change | -196.97% | 43.48% |
Pretax Income | -$8.750M | -$8.490M |
YoY Change | 3.06% | 32.04% |
Income Tax | $22.00K | $3.000K |
% Of Pretax Income | ||
Net Earnings | -$8.767M | -$8.491M |
YoY Change | 3.25% | 31.99% |
Net Earnings / Revenue | -983.95% | -2774.84% |
Basic Earnings Per Share | ||
Diluted Earnings Per Share | -$1.898M | -$1.887M |
COMMON SHARES | ||
Basic Shares Outstanding | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2016 Q2 | 2015 Q2 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $53.54M | $86.00M |
YoY Change | -37.74% | 91.54% |
Cash & Equivalents | $53.54M | $86.00M |
Short-Term Investments | ||
Other Short-Term Assets | $1.030M | $800.0K |
YoY Change | 28.75% | 12.68% |
Inventory | $510.0K | $70.00K |
Prepaid Expenses | ||
Receivables | $100.0K | $130.0K |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $55.18M | $87.00M |
YoY Change | -36.57% | 90.21% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $3.460M | $3.380M |
YoY Change | 2.37% | 237.66% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $210.0K | $190.0K |
YoY Change | 10.53% | 115.91% |
Total Long-Term Assets | $3.670M | $3.560M |
YoY Change | 3.09% | 204.79% |
TOTAL ASSETS | ||
Total Short-Term Assets | $55.18M | $87.00M |
Total Long-Term Assets | $3.670M | $3.560M |
Total Assets | $58.85M | $90.56M |
YoY Change | -35.02% | 93.06% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $480.0K | $1.030M |
YoY Change | -53.4% | 22.77% |
Accrued Expenses | $1.860M | $2.730M |
YoY Change | -31.87% | 56.99% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $30.00K |
YoY Change | -100.0% | |
Long-Term Debt Due | $0.00 | |
YoY Change | -100.0% | |
Total Short-Term Liabilities | $3.140M | $5.230M |
YoY Change | -39.96% | 69.53% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $870.0K | $20.00K |
YoY Change | 4250.0% | |
Total Long-Term Liabilities | $870.0K | $20.00K |
YoY Change | 4250.0% | |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $3.140M | $5.230M |
Total Long-Term Liabilities | $870.0K | $20.00K |
Total Liabilities | $4.000M | $5.240M |
YoY Change | -23.66% | 69.58% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | ||
YoY Change | ||
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $54.84M | $85.32M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $58.85M | $90.56M |
YoY Change | -35.02% | 93.06% |
Cashflow Statement
Concept | 2016 Q2 | 2015 Q2 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$8.767M | -$8.491M |
YoY Change | 3.25% | 31.99% |
Depreciation, Depletion And Amortization | $251.0K | $135.0K |
YoY Change | 85.93% | 40.63% |
Cash From Operating Activities | -$8.540M | -$6.300M |
YoY Change | 35.56% | -285.29% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $12.00K | $1.135M |
YoY Change | -98.94% | 376.89% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | -$10.00K | -$1.140M |
YoY Change | -99.12% | 375.0% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | $46.10M | |
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 0.000 | 43.29M |
YoY Change | -100.0% | 13018.18% |
NET CHANGE | ||
Cash From Operating Activities | -8.540M | -6.300M |
Cash From Investing Activities | -10.00K | -1.140M |
Cash From Financing Activities | 0.000 | 43.29M |
Net Change In Cash | -8.550M | 35.85M |
YoY Change | -123.85% | 954.41% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$8.540M | -$6.300M |
Capital Expenditures | $12.00K | $1.135M |
Free Cash Flow | -$8.552M | -$7.435M |
YoY Change | 15.02% | -335.14% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2016Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
5056000 | |
CY2015Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
4622000 | |
CY2016Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4444000 | |
CY2016Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
22000 | |
CY2016Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8767000 | |
CY2016Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.09 | |
CY2016Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
54843000 | |
CY2016Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
58847000 | |
CY2016Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2016Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | |
CY2016Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
92389730 | |
CY2016Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
92389730 | |
CY2016Q2 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
674000 | |
CY2015Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.10 | |
CY2016Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
92391964 | |
CY2015Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
82993966 | |
CY2016Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
251000 | |
CY2015Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
135000 | |
CY2016Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
5000 | |
CY2015Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
38000 | |
CY2016Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1429000 | |
CY2015Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1780000 | |
CY2016Q2 | us-gaap |
Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
|
0 | |
CY2015Q2 | us-gaap |
Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
|
-95000 | |
CY2016Q2 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-156000 | |
CY2015Q2 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
132000 | |
CY2016Q2 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
178000 | |
CY2015Q2 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
3000 | |
CY2016Q2 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
41000 | |
CY2015Q2 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-256000 | |
CY2016Q2 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-306000 | |
CY2015Q2 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-357000 | |
CY2016Q2 | onvo |
Revenue From Research Collaborations
RevenueFromResearchCollaborations
|
213000 | |
CY2016Q2 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
4000 | |
CY2015Q2 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
83000 | |
CY2016Q2 | us-gaap |
Revenues
Revenues
|
891000 | |
CY2015Q2 | us-gaap |
Revenues
Revenues
|
306000 | |
CY2016Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
168000 | |
CY2015Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
0 | |
CY2015Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4142000 | |
CY2016Q2 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
9668000 | |
CY2015Q2 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
8764000 | |
CY2016Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8777000 | |
CY2015Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8458000 | |
CY2016Q2 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
-5000 | |
CY2015Q2 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
-38000 | |
CY2015Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
3000 | |
CY2015Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8491000 | |
CY2016Q2 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-735000 | |
CY2015Q2 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-611000 | |
CY2016Q2 | onvo |
Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
|
-36000 | |
CY2015Q2 | onvo |
Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
|
-8000 | |
CY2016Q2 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-319000 | |
CY2015Q2 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
1193000 | |
CY2016Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-8541000 | |
CY2015Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-6295000 | |
CY2016Q2 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
12000 | |
CY2015Q2 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1135000 | |
CY2016Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-12000 | |
CY2015Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-1135000 | |
CY2016Q2 | onvo |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
0 | |
CY2015Q2 | onvo |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
43214000 | |
CY2016Q2 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | |
CY2015Q2 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
77000 | |
CY2016Q2 | us-gaap |
Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
|
0 | |
CY2015Q2 | us-gaap |
Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
|
3000 | |
CY2016Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
0 | |
CY2015Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
43288000 | |
CY2016Q2 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-8553000 | |
CY2015Q2 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
35858000 | |
CY2015Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
50142000 | |
CY2015Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
86000000 | |
CY2016Q2 | us-gaap |
Interest Paid
InterestPaid
|
0 | |
CY2015Q2 | us-gaap |
Interest Paid
InterestPaid
|
0 | |
CY2016Q2 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
22000 | |
CY2015Q2 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
3000 | |
CY2015Q2 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
138000 | |
CY2015Q2 | onvo |
Leasehold Improvements Funded By Lease Incentive
LeaseholdImprovementsFundedByLeaseIncentive
|
337000 | |
CY2016Q2 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Significant estimates used in preparing the condensed consolidated financial statements include those assumed in computing the valuation of warrants, revenue recognized under the proportional performance model, the valuation of stock-based compensation expense, and the valuation allowance on deferred tax assets. </p></div> | |
CY2016Q2 | us-gaap |
Revenue Recognition Multiple Element Arrangements
RevenueRecognitionMultipleElementArrangements
|
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Revenue arrangements with multiple deliverables </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company follows ASC 605-25 <font style="font-style:italic;">Revenue Recognition – Multiple-Element Arrangements</font> for revenue arrangements that contain multiple deliverables. Judgment is required to properly identify the accounting units of the multiple deliverable transactions and to determine the manner in which revenue should be allocated among the accounting units. Moreover, judgment is used in interpreting the commercial terms and determining when all criteria of revenue recognition have been met for each deliverable in order for revenue recognition to occur in the appropriate accounting period. For multiple deliverable agreements, consideration is allocated at the inception of the agreement to all deliverables based on their relative selling price. The relative selling price for each deliverable is determined using vendor-specific objective evidence (“VSOE”) of selling price or third-party evidence of selling price if VSOE does not exist. If neither VSOE nor third-party evidence of selling price exists, the Company uses its best estimate of the selling price for the deliverable. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While changes in the allocation of the arrangement consideration between the units of accounting will not affect the amount of total revenue recognized for a particular sales arrangement, any material changes in these allocations could impact the timing of revenue recognition, which could affect the Company’s results of operations. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company periodically receives license fees for non-exclusive research licensing associated with funded research projects. License fees under these arrangements are recognized over the term of the contract or development period as it has been determined that such licenses do not have stand-alone value. </p></div> | |
CY2016Q2 | us-gaap |
Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
|
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Product revenue </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes product revenue at the time of shipment to the customer, provided all other revenue recognition criteria have been met. To date, the Company has not recognized significant revenue from commercial product sales.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As our commercial sales increase, we expect to establish a reserve for estimated product returns that will be recorded as a reduction to revenue. This reserve will be maintained to account for future return of products sold in the current period. The reserve will be reviewed quarterly and will be estimated based on an analysis of our historical experience related to product returns.</p></div> | |
CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
5862904 | |
CY2016Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.79 | |
CY2016Q2 | us-gaap |
Dilutive Securities
DilutiveSecurities
|
0 | |
CY2015Q2 | us-gaap |
Dilutive Securities
DilutiveSecurities
|
0 | |
CY2016Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
11600000 | |
CY2015Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
10200000 | |
CY2011 | onvo |
Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
|
P5Y | |
CY2012 | onvo |
Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
|
P5Y | |
CY2016Q2 | onvo |
Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
|
0 | |
CY2015Q2 | onvo |
Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
|
38234 | |
CY2016Q2 | onvo |
Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
|
0 | |
CY2015Q2 | onvo |
Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
|
30186 | |
CY2016Q2 | us-gaap |
Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
0 | |
CY2015Q2 | us-gaap |
Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
38234 | |
CY2016Q2 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
0 | |
CY2015Q2 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
25503 | |
CY2016Q2 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | |
CY2015Q2 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
25503 | |
CY2016Q2 | onvo |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Upon Return Of Common Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUponReturnOfCommonShares
|
2259 | |
CY2015Q2 | onvo |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Upon Return Of Common Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUponReturnOfCommonShares
|
2259 | |
CY2016Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
9614627 | |
CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
416640 | |
CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
22970 | |
CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
10008297 | |
CY2016Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
3.21 | |
CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
3.64 | |
CY2016Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.72 | |
CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
4.55 | |
CY2016Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
1927137 | |
CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | |
CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
7092419 | |
CY2016Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
5416930 | |
CY2016Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y2M5D | |
CY2016Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y2M5D | |
CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
CY2015Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.7130 | |
CY2015Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.7425 | |
CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
2.03 | |
CY2015Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.22 | |
CY2016Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
11840000 | |
CY2014Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
145000 | |
CY2014Q4 | onvo |
Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
|
P5Y | |
CY2014Q4 | onvo |
Warrant Earning Period Through Issuance Of Common Stock
WarrantEarningPeriodThroughIssuanceOfCommonStock
|
P17M | |
CY2016Q2 | onvo |
Number Of Warrant Shares Vested Upon Satisfaction Of Specific Performance Metrics
NumberOfWarrantSharesVestedUponSatisfactionOfSpecificPerformanceMetrics
|
95000 | |
CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0120 | |
CY2015Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0165 | |
CY2016Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | |
CY2015Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.734 | |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0121 | |
CY2016Q2 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
17150435 | |
CY2016Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
25000000 | |
CY2016Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2016Q2 | onvo |
Number Of Non Cancelable Leases
NumberOfNonCancelableLeases
|
3 | |
CY2016Q2 | onvo |
Operating Leases Monthly Rent Expense
OperatingLeasesMonthlyRentExpense
|
83000 | |
CY2016Q2 | us-gaap |
Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
|
0.03 | |
CY2016Q2 | onvo |
Office Space Area Under Lease Agreement
OfficeSpaceAreaUnderLeaseAgreement
|
30895 | |
CY2016Q2 | us-gaap |
Lease Expiration Date1
LeaseExpirationDate1
|
2021-09-01 | |
CY2016Q2 | onvo |
Lease Option Termination Description
LeaseOptionTerminationDescription
|
option to terminate on or after September 1, 2019 | |
CY2016Q2 | onvo |
Additional Office Space
AdditionalOfficeSpace
|
14500 | |
CY2015Q1 | onvo |
Additional Leased Office Space
AdditionalLeasedOfficeSpace
|
5803 | |
CY2015Q1 | us-gaap |
Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
|
P36M | |
CY2015Q1 | onvo |
Lease Rental Period Start Date
LeaseRentalPeriodStartDate
|
2015-02-01 | |
CY2015Q1 | onvo |
Lease Rental Period End Date
LeaseRentalPeriodEndDate
|
2018-01-31 | |
CY2015Q1 | onvo |
Operating Leases Monthly Base Rent Expense
OperatingLeasesMonthlyBaseRentExpense
|
12000 | |
CY2015Q1 | us-gaap |
Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
|
0.03 | |
CY2015Q4 | onvo |
Additional Leased Office Space
AdditionalLeasedOfficeSpace
|
12088 | |
CY2015Q4 | us-gaap |
Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
|
P12M | |
CY2015Q4 | onvo |
Lease Rental Period Start Date
LeaseRentalPeriodStartDate
|
2016-02-01 | |
CY2015Q4 | onvo |
Lease Rental Period End Date
LeaseRentalPeriodEndDate
|
2017-01-31 | |
CY2015Q4 | onvo |
Operating Leases Monthly Base Rent Expense
OperatingLeasesMonthlyBaseRentExpense
|
15000 | |
CY2016Q2 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
303000 | |
CY2015Q2 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
277000 | |
CY2016Q2 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
976000 | |
CY2016Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
1148000 | |
CY2016Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
1044000 | |
CY2016Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
1072000 | |
CY2016Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
1104000 | |
CY2016Q2 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
468000 | |
CY2016Q2 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
5812000 |